Physician profile
Adelnery Gonzalez
NPI 1437192655
$2,024.28
in general payments reported to CMS, 2019-2025
19 companies · $220 in 2025
The $220 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $309 · 2021: $230 · 2022: $230 · 2023: $426 · 2024: $457 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,103.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $393.53 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $311.00 | 2023-2024 | Qelbree, Qelbree |
| Tris Pharma INC | $206.00 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $182.98 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $138.97 | 2020-2024 | Vaxneuvance, Rotateq, Proquad |
| Cranial Technologies, INC | $137.58 | 2021-2025 | Doc Band |
| Pfizer INC. | $114.66 | 2021-2025 | |
| Gm Pharmaceuticals, INC. | $92.53 | 2024 | Vanacof |
| Sanofi Pasteur INC. | $86.55 | 2020-2023 | |
| Glaxosmithkline, LLC. | $72.36 | 2020-2025 | Rotarix, Bexsero, Pediarix |
| Shire North American Group INC | $50.81 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.17 | 2020 | |
| Abbott Laboratories | $50.01 | 2025 | Alere Cholestech Ldx |
| Verrica Pharmaceuticals INC. | $34.82 | 2024-2025 | Ycanth |
| Seqirus USA INC | $31.21 | 2021-2023 | Flucelvax Quadrivalent |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $21.60 | 2020 | |
| Vertical Pharmaceuticals, LLC | $21.08 | 2025 | Relexxii |
| Arbor Pharmaceuticals, INC. | $14.96 | 2020 | |
| Abbvie INC. | $13.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adelnery Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.